These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 36797393

  • 1. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
    Katayoshi T, Uehata S, Nakashima N, Nakajo T, Kitajima N, Kageyama M, Tsuji-Naito K.
    Sci Rep; 2023 Feb 16; 13(1):2786. PubMed ID: 36797393
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
    Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V.
    Geroscience; 2023 Feb 16; 45(1):29-43. PubMed ID: 36482258
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
    Yamaguchi S, Irie J, Mitsuishi M, Uchino Y, Nakaya H, Takemura R, Inagaki E, Kosugi S, Okano H, Yasui M, Tsubota K, Hayashi K, Yoshino J, Itoh H.
    Endocr J; 2024 Feb 28; 71(2):153-169. PubMed ID: 38191197
    [Abstract] [Full Text] [Related]

  • 4. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.
    Morifuji M, Higashi S, Ebihara S, Nagata M.
    Geroscience; 2024 Oct 28; 46(5):4671-4688. PubMed ID: 38789831
    [Abstract] [Full Text] [Related]

  • 5. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.
    Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M.
    J Int Soc Sports Nutr; 2021 Jul 08; 18(1):54. PubMed ID: 34238308
    [Abstract] [Full Text] [Related]

  • 6. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration.
    Kuerec AH, Wang W, Yi L, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V, Maier AB.
    Mech Ageing Dev; 2024 Apr 08; 218():111917. PubMed ID: 38430946
    [Abstract] [Full Text] [Related]

  • 7. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
    Pencina KM, Lavu S, Dos Santos M, Beleva YM, Cheng M, Livingston D, Bhasin S.
    J Gerontol A Biol Sci Med Sci; 2023 Jan 26; 78(1):90-96. PubMed ID: 35182418
    [Abstract] [Full Text] [Related]

  • 8. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
    Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, Tobe K, Nakagawa T.
    Front Nutr; 2022 Jan 26; 9():868640. PubMed ID: 35479740
    [Abstract] [Full Text] [Related]

  • 9. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.
    Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, Sekine R, Fukamizu Y, Sato T, Sakurai T, Sato J, Ino K, Kubota N, Nakagawa T, Kadowaki T, Yamauchi T.
    NPJ Aging; 2022 May 01; 8(1):5. PubMed ID: 35927255
    [Abstract] [Full Text] [Related]

  • 10. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
    Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J.
    Adv Nutr; 2023 Nov 01; 14(6):1416-1435. PubMed ID: 37619764
    [Abstract] [Full Text] [Related]

  • 11. Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases.
    Deng H, Ding D, Ma Y, Zhang H, Wang N, Zhang C, Yang G.
    Int J Mol Sci; 2024 Sep 02; 25(17):. PubMed ID: 39273473
    [Abstract] [Full Text] [Related]

  • 12. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women.
    Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T.
    Sci Rep; 2022 Aug 24; 12(1):14442. PubMed ID: 36002548
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
    Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H.
    Endocr J; 2020 Feb 28; 67(2):153-160. PubMed ID: 31685720
    [Abstract] [Full Text] [Related]

  • 14. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
    Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, Sindelar M, Pietka T, Patterson BW, Imai SI, Klein S.
    Science; 2021 Jun 11; 372(6547):1224-1229. PubMed ID: 33888596
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
    Yamane T, Imai M, Bamba T, Uchiyama S.
    Clin Nutr ESPEN; 2023 Aug 11; 56():83-86. PubMed ID: 37344088
    [Abstract] [Full Text] [Related]

  • 16. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
    Ru M, Wang W, Zhai Z, Wang R, Li Y, Liang J, Kothari D, Niu K, Wu X.
    Food Funct; 2022 Jul 18; 13(14):7507-7519. PubMed ID: 35678708
    [Abstract] [Full Text] [Related]

  • 17. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
    Soma M, Lalam SK.
    Mol Biol Rep; 2022 Oct 18; 49(10):9737-9748. PubMed ID: 35441939
    [Abstract] [Full Text] [Related]

  • 18. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation.
    Kim LJ, Chalmers TJ, Madawala R, Smith GC, Li C, Das A, Poon EWK, Wang J, Tucker SP, Sinclair DA, Quek LE, Wu LE.
    FEBS Lett; 2023 Sep 18; 597(17):2196-2220. PubMed ID: 37463842
    [Abstract] [Full Text] [Related]

  • 19. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
    Kahn B, Borrelli M, Libby T.
    J Drugs Dermatol; 2022 Oct 01; 21(10):1129-1132. PubMed ID: 36219044
    [Abstract] [Full Text] [Related]

  • 20. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.
    Akasaka H, Nakagami H, Sugimoto K, Yasunobe Y, Minami T, Fujimoto T, Yamamoto K, Hara C, Shiraki A, Nishida K, Asano K, Kanou M, Yamana K, Imai SI, Rakugi H.
    Geriatr Gerontol Int; 2023 Jan 01; 23(1):38-43. PubMed ID: 36443648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.